Clinical trials
Phase 2 Connective Tissue Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 6 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Suspended | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Center for Research Resources (NCRR) | 5 |
| Amgen | 2 |
| Caliway Biopharmaceuticals Co., Ltd. | 2 |
| Complexa, Inc. | 2 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| Alumis Inc | 1 |
| Bastiaan Driehuys | 1 |
| Beeline Medicines Corporation | 1 |
| Beijing Hospital | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Connective Tissue Diseases | 34 |
| Arthritis | 13 |
| Rare Diseases | 10 |
| Immune System Diseases | 8 |
| Autoimmune Diseases | 7 |
| Scleroderma, Systemic | 7 |
| Skin Diseases | 7 |
| Lupus Erythematosus, Systemic | 6 |
| Scleroderma, Diffuse | 5 |
| Familial Primary Pulmonary Hypertension | 4 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.